Literature DB >> 12808204

Xenotransplantation of porcine pancreatic endocrine cells to total pancreatectomized dogs.

Kazuya Edamura1, Shin Itakura, Koko Nasu, Yukiko Iwami, Hiroyuki Ogawa, Nobuo Sasaki, Hisako Ohgawara.   

Abstract

Xenotransplantation of porcine pancreatic endocrine (PE) cells in a diffusion chamber, a bioartificial endocrine pancreas (Bio-AEP), was conducted to total pancreatectomized dogs. Six pancreatectomized dogs were divided into two groups of 3 dogs each. In three dogs of the control group, exogenous insulin was administered twice a day for 30 weeks to maintain fasting blood glucose (FBG) levels within the normal range. The remaining three dogs were implanted with Bio-AEPs (implantation group), in addition to daily insulin administration. In the implantation group, Bio-AEPs containing 1.3 to 1.8 x 10(7) cells per kg of body weight of the recipient were implanted without fixation into the abdominal cavity. In the control group, exogenous insulin requirements did not decrease during the experimental period, whereas it significantly decreased for a certain period (3, 11, 17 weeks) after implantation in all implanted dogs. In the implantation group, laparotomy was performed after FBG and the exogenous insulin requirement increased again and Bio-AEPs were removed. Two Bio-AEPs were completely destroyed, and the remaining one was encapsulated by thin fibrous tissue. In this dog, effusion was present within the capsule, but the Bio-AEP was not destroyed. Histopathologically, the necrosis, presumably caused by hypoxia, of the PE-cells was observed on transmission electron microscopy. In conclusion, Bio-AEP could function for a certain period after implantation in this study. However, more preclinical researches should be needed to apply this technique for the treatment of diabetic dogs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808204     DOI: 10.1292/jvms.65.549

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  5 in total

Review 1.  Enhancing clinical islet transplantation through tissue engineering strategies.

Authors:  Jaime A Giraldo; Jessica D Weaver; Cherie L Stabler
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  Preliminary Results of the Influence of Duodenojejunal Bypass in a Porcine Model of Streptozotocin-Induced Diabetes Mellitus.

Authors:  S Hiridis; K Konstantinidis; E Menenakos; Th Diamantis; A Papalois; G Zografos
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

3.  Goettingen Minipigs (GMP): Comparison of Two Different Models for Inducing Diabetes.

Authors:  Armin Strauss; Vasily Moskalenko; Christian Tiurbe; Irina Chodnevskaja; Stephan Timm; Verena A Wiegering; Christoph-Thomas Germer; Karin Ulrichs
Journal:  Diabetol Metab Syndr       Date:  2012-03-05       Impact factor: 3.320

4.  Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation.

Authors:  Alfredo Cappariello; Riccardo Paone; Antonio Maurizi; Mattia Capulli; Nadia Rucci; Maurizio Muraca; Anna Teti
Journal:  Biomaterials       Date:  2015-01-17       Impact factor: 12.479

5.  Pravastatin improves glucose regulation and biocompatibility of agarose encapsulated porcine islets following transplantation into pancreatectomized dogs.

Authors:  Lawrence S Gazda; Horatiu V Vinerean; Melissa A Laramore; Richard D Hall; Joseph W Carraway; Barry H Smith
Journal:  J Diabetes Res       Date:  2014-05-19       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.